CurifyLabs

Finland
Helsinki, Uusimaa, Finland, Finland

Company profile

CurifyLabs company profile

Founded in 2021, CurifyLabs is transforming how personalized medicines are made. Its Compounding System Solution combines proprietary software, GMP-manufactured excipients, and advanced 3D printing technology to bring consistency, safety, and speed to personalized compounding. CurifyLabs partners with hospitals and pharmacies worldwide to help deliver the next era of precision healthcare.

Business identity

Contact email
[email protected]
Phone number
+358 400 188781
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-15

Headquarters

Postal code
Finland
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
6
Total equity funding
$11.1M
Last funding
Seed / $7.6M / 2025-05-27
Last equity funding
Seed / $7.6M
Investors
5
Lead investors
3
Founders
2
Articles
32

Founders and investors

Founders

Charlotta TopeliusNiklas Sandler Topelius

Lead investors

Business FinlandLifeline VenturesSpringvest

Investors

Apteekkien EläkekassaAvohoidon TutkimussäätiöBusiness FinlandLifeline VenturesSpringvest